Assessing breathing patterns during non-invasive ventilation
Official title: Breathing Route in COPD and OHS Patients on Long-term Home Non-invasive Ventilation: An Experimental Study
Run by Fisher and Paykel Healthcare · NCT06682286 · Data updated 2026-11-12
This study is testing which of two different masks used in non-invasive ventilation helps people with COPD and Obesity Hypoventilation Syndrome breathe better and feel more comfortable.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Fisher and Paykel Healthcare Industry-sponsored |
| Locations | 1 site (Auckland) |
| Status | Recruiting |
| Started | January 24, 2025 |
| Main results expected | September 2025 |
| Study ends | September 2025 |
| Registry record updated | May 11, 2025 |
| Trial ID | NCT06682286 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old who are prescribed nocturnal NIV for COPD or OHS and can complete an overnight sleep study.
✕Probably not a fit
Patients with uncontrolled sleep apnea or those requiring high levels of airway pressure support may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of different masks used in non-invasive ventilation (NIV) for patients with Chronic Obstructive Pulmonary Disease (COPD) and Obesity Hypoventilation Syndrome (OHS). Participants will undergo a series of breathing assessments while using two different NIV masks to determine which provides better comfort and breathing support. The study involves both awake and overnight assessments to gather comprehensive data on breathing patterns and mask efficacy. The goal is to improve long-term NIV management and patient outcomes.
Why it matters
Potential benefit: If successful, this study could enhance the comfort and effectiveness of NIV therapy for patients with COPD and OHS, leading to better symptom management and quality of life.
How similar studies have gone: While studies on NIV have been conducted, this specific approach to comparing mask types in long-term users is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age over 18 years * Prescribed nocturnal NIV for COPD or OHS * Able to complete an overnight sleep study * Comfortable to sleep on a standard double bed * Capacity to complete informed consent Exclusion Criteria: * Uncontrolled sleep apnea (Apnea-hypopnea index (AHI) over 15 events/hour off personal NIV device data) * Prescribed IPAP above 25 cmH2O * Self-reported pregnancy * Allergic to adhesive of the sensors * Self-reported cold/flu symptoms
Where it's running
-
Fisher and Paykel Healthcare Sleep Laboratory
Auckland, New Zealand Recruiting
Study contacts
- Principal investigator: William Good, Medical degree — Middlemore Hospital, New Zealand
- Study coordinator: Valeria Mereacre, PhD Physiology
- Email: val.mereacre@fphcare.co.nz
- Phone: 0064 2102819036
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Enhanced COPD care for people being checked for lung cancer
This project will test whether finding and treating COPD early in people being checked for possible lung cancer helps symptoms, lung function, and overall care.
-
High-Flow Nasal Cannula vs Noninvasive Ventilation in COPD with Hypercapnia
This study tests whether a high-flow nasal cannula can better support gas exchange and comfort compared with noninvasive ventilation in COPD patients with mild-to-moderate elevated CO2.
-
Risk-based lung cancer screening in COPD patients using ML and clinical models
This study tests whether a PLCOm2012 risk model plus a machine learning model can spot COPD patients at high risk for lung cancer to see if they benefit from low-dose CT screening.
-
Biologics for Type 2 Inflammation in Asthma and COPD in Real World
This real-world study tests whether six biologic drugs can reduce flare-ups and improve symptoms in adults with asthma or COPD treated in routine care in China.
-
Nebulized vs handheld maintenance therapy for COPD patients with limited benefit from inhalers
This trial tests whether switching to a breath-enhanced nebulizer with similar COPD meds helps people who don’t get enough relief from their current handheld inhalers.
-
New breathing tests to diagnose airway disease in hospital and community settings
This study tests whether newer breathing tests can correctly diagnose COPD and airway disease as well as standard spirometry, using tests like capnography and oscillometry in hospital and community settings.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.